biote Corp. Class A BTMD 深 沪
已收盘 07-02 16:00:00 美东时间
2.17
+0.180
+9.05%
华盛通- 最 高2.1992
- 今 开2.01
- 成交量 26.52万股
- 最 低 2.0075
- 昨 收 1.99
- 总市值 8155.14万
- 52周最高 4.7498
- 市盈率 静 2.94
- 换手率 0.71%
- 52周最低 1.27
- 委 比 -3.14%
- 总股本 3758.13万
- 历史最高 12.08
- 量 比 0.26
- 振 幅 9.63%
- 历史最低 1.27
- 每 手 1
- 风险率 0.72%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Biote Reaffirms FY26 Guidance For Revenue Above $190M And Adjusted EBITDA Above $38M
Biote reaffirmed its full year 2026 guidance for revenue above $190 million, Adjusted EBITDA above $38 million, and a return to procedure revenue growth in the second half of this year.
05-28 21:12
Biote Appoints CFO And Chief Business Officer Bob Peterson As Interim CEO And Director, Effective June 8; Bret Christensen Steps Down As CEO
Biote (NASDAQ:BTMD), a leader in innovative hormone optimization and healthy aging solutions that advance the healthspan of our practitioners' patients, today announced that Bob Peterson, Chief Financial Officer and
05-28 21:11
ImmunityBio acquiring U.S. rights to Tokyo strain of BCG
ImmunityBio (IBRX) on Saturday announced a licensing deal to acquire exclusive U.S. rights to a bladder cancer therapy called Bacillus Calmette-Guerin (BCG) treatment from Japan BCG Laboratory, a Japa...
05-17 02:11
Why Is HCW Biologics Stock Gaining Today?
HCW Biologics shares soared Friday after the company reported stronger quarterly results, advanced a key licensing deal and reaffirmed upcoming autoimmune clinical data milestones despite ongoing going-concern risks.
05-16 01:35
Full Transcript: Arrive AI Q1 2026 Earnings Call
Arrive AI (NASDAQ:ARAI) released first-quarter financial results and hosted an ...
05-15 21:29
Precipio Announces Q1 2026 Financial Results
Precipio, Inc. reported first-quarter 2026 revenue of $6.71M, flat from Q4-2025 but up 36% year-over-year. Product revenue declined temporarily due to delayed shipments. Adjusted EBITDA was $(0.16)M, impacted by CMS cuts, product shipment delays, and hiring costs. Cash flow was positive $60K. CEO Ilan Danieli noted underlying growth, particularly in the expanding product pipeline, expecting second-half growth.
05-14 21:00
Polaryx Therapeutics Receives GHP Magazine’s Healthcare & Pharmaceuticals Awards
Polaryx Therapeutics has been awarded two 2026 GHP Magazine Healthcare & Pharmaceutical Awards for its excellence in pediatric lysosomal storage disease therapeutics and rare neurodegenerative disease drug development. The company, focused on rare pediatric lysosomal storage disorders, was recognized for its innovation, market impact, and contributions to patient outcomes. CEO Alex Yang highlighted the importance of addressing unmet needs in lyso...
05-14 13:15
Management team’s 2025 market-based Options have vested
Precipio, Inc. announced that its 2025 employee stock options granted to management vested due to a 400% increase in its share price from $6.06 to a 10-day VWAP of $30.30. The Company replaced standard time-based vesting with a market-based structure, where options vest upon reaching a specified share price. CEO Ilan Danieli highlighted this as aligning management incentives with shareholders. In 2026, management agreed to a similar structure wit...
05-13 21:00
aTyr Pharma to Participate in Upcoming Investor Conferences
aTyr Pharma, a clinical-stage biotech company, announced its participation in two investor conferences in May and June 2026. The RBC Capital Markets Global Healthcare Conference will be held on May 20 in New York, featuring 1x1 investor meetings. The Jefferies Global Healthcare Conference on June 4 will include a fireside chat with CEO Sanjay S. Shukla, with a webcast available on the company’s website. aTyr focuses on developing therapies for fi...
05-13 20:01
Immunic Q1 net loss widens on higher R&D spends
Immunic Q1 net loss widens on higher R&D spends Overview US biotechnology firm's Q1 net loss widened to $32.6 mln, or $1.08 per share Company raised $200 mln in private placement, boosting cash to $186.6 mln Outlook Immunic expects to fund operations into late 2027 with current cash position Result
05-13 18:42
